{
  "type": "hyp",
  "text": "In this work we report that these anergic T cells are defective in their ability to up-regulate protein binding and transactivation at two critical IL-2 DNA enhancer elements: NF-AT (nuclear factor of activated T cells; a sequence that binds a heterotrimeric NFATp Fos and Jun protein complex) and Activator Protein-1 (AP-1) (that binds Fos and Jun heterodimers).\n",
  "self": {
    "NER": {
      "answers": [
        "two",
        "IL-2",
        "Jun",
        "Activator",
        "Fos",
        "Jun"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "How many critical IL-2 DNA enhancer elements are there?",
          "What is the key DNA enhancer element in anergic T cells?",
          "What is the name of the protein complex that binds NF-ATp Fos",
          "What is AP-1?",
          "What is the name of the complex that binds NF-ATp?",
          "What is the name of the protein complex that binds NF-ATp Fos"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "this work",
        "we",
        "these anergic T cells",
        "their ability",
        "transactivation",
        "two critical IL-2 DNA enhancer elements",
        "NF-AT",
        "nuclear factor",
        "activated T cells",
        "a sequence",
        "a heterotrimeric NFATp Fos and Jun protein complex",
        "Activator Protein-1 (AP-1",
        "(that binds",
        "Fos"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What did the authors of the study report about anergic T cells?",
          "What is the name of the molecule that binds Fos and Jun?",
          "What is defective in their ability to up-regulate protein binding and transactivation?",
          "What are anergic T cells defective in?",
          "What is one of the two critical IL-2 DNA enhancer elements?",
          "What do anergic T cells fail to up-regulate protein binding and transactiv",
          "What is the name of the nuclear factor of activated T cells?",
          "What is NF-AT?",
          "What is NF-AT a nuclear factor of?",
          "What binds a heterotrimeric NFATp Fos and Jun?",
          "What does NF-AT bind?",
          "What is the name of the protein that binds Fos and Jun heterodimers",
          "What is AP-1?",
          "What is the name of the complex that binds NF-ATp?"
        ]
      }
    }
  },
  "asked": {
    "What is the dominant negative allele of c-Raf-1?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.023269951343536377,
        "ground_truth": {
          "301": {
            "bertscore": 0.6379930377006531,
            "f1": 0
          },
          "c": {
            "bertscore": 0.6910487413406372,
            "f1": 0
          },
          "(Raf": {
            "bertscore": 0.6650149822235107,
            "f1": 0
          }
        }
      }
    },
    "What constructs were triggered by hypoxia?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00011551380157470703,
        "ground_truth": {
          "kappa B reporter": {
            "bertscore": 0.6565632224082947,
            "f1": 0
          }
        }
      }
    },
    "What was the main cause of the NF-kappa B binding?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.002633988857269287,
        "ground_truth": {
          "hypoxia": {
            "bertscore": 0.6694233417510986,
            "f1": 0
          }
        }
      }
    },
    "What inhibited I kappa B alpha degradation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0031662583351135254,
        "ground_truth": {
          "Pretreatment": {
            "bertscore": 0.7354638576507568,
            "f1": 0
          }
        }
      }
    },
    "What did the treatment of with ptyrosine kinase inhibitors": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.011982083320617676,
        "ground_truth": {
          "cells": {
            "bertscore": 0.6847147345542908,
            "f1": 0
          }
        }
      }
    },
    "What did pretreatment of cells with inhibit I kappa B alpha degradation?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00039571523666381836,
        "ground_truth": {
          "protein tyrosine kinase inhibitors": {
            "bertscore": 0.5819656848907471,
            "f1": 0
          }
        }
      }
    },
    "What is the name of the allele of c-Raf-1?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.03484845161437988,
        "ground_truth": {
          "the dominant negative allele": {
            "bertscore": 0.6859081387519836,
            "f1": 0
          }
        }
      }
    },
    "What kappa B alpha degradation was inhibited by c-Ra": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0069817304611206055,
        "ground_truth": {
          "I": {
            "bertscore": 0.6798964142799377,
            "f1": 0
          }
        }
      }
    },
    "What did the treatment of cells with c-Raf-1 inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.005338609218597412,
        "ground_truth": {
          "kappa B alpha degradation NF-kappa B binding": {
            "bertscore": 0.5837191343307495,
            "f1": 0
          }
        }
      }
    },
    "What did the pretreatment of cells with c-Raf-1 inhibit?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.003871917724609375,
        "ground_truth": {
          "transactivation": {
            "bertscore": 0.7052720189094543,
            "f1": 0
          }
        }
      }
    }
  }
}